NAECB COPD Management 3 — Questions and Answers
Question 1: A COPD patient presents with increased sputum purulence, worsening dyspnea, and increased sputum volume. These three features together define which clinical condition?
- Type 1 (Anthonisen) acute exacerbation of COPD (Correct answer)
- Stable COPD with mucus hypersecretion
- Acute respiratory distress syndrome
- Community-acquired pneumonia
Correct answer: Type 1 (Anthonisen) acute exacerbation of COPD
The Anthonisen criteria define a Type 1 exacerbation when all three cardinal symptoms (increased dyspnea, sputum volume, and sputum purulence) are present.
Question 2: Long-term oxygen therapy (LTOT) in COPD is indicated when resting SpO2 is at or below what threshold?
- 88% (Correct answer)
- 90%
- 92%
- 85%
Correct answer: 88%
LTOT is indicated when resting SpO2 is ≤88% (or PaO2 ≤55 mmHg) on room air, as this level of hypoxemia is associated with increased mortality.
Question 3: Which roflumilast mechanism makes it useful in preventing COPD exacerbations in severe disease?
- Selective phosphodiesterase-4 inhibition reducing airway inflammation (Correct answer)
- Beta-2 receptor agonism causing bronchodilation
- Muscarinic receptor blockade
- Leukotriene receptor antagonism
Correct answer: Selective phosphodiesterase-4 inhibition reducing airway inflammation
Roflumilast selectively inhibits PDE-4, reducing cAMP breakdown and thereby dampening airway inflammation without direct bronchodilatory effects.
Question 4: When teaching pursed-lip breathing to a COPD patient, what is the primary therapeutic goal?
- Slow exhalation to prevent dynamic airway collapse and reduce air trapping (Correct answer)
- Increase inspiratory muscle strength
- Raise respiratory rate to improve minute ventilation
- Enhance bronchodilator deposition
Correct answer: Slow exhalation to prevent dynamic airway collapse and reduce air trapping
Pursed-lip breathing slows exhalation and creates back-pressure that splints small airways open, reducing dynamic collapse and improving air emptying.
Question 5: In COPD management, the LAMA class of medications primarily works by:
- Blocking muscarinic receptors to reduce bronchoconstriction and mucus secretion (Correct answer)
- Stimulating beta-2 receptors to relax airway smooth muscle
- Inhibiting phosphodiesterase enzymes
- Suppressing eosinophilic airway inflammation
Correct answer: Blocking muscarinic receptors to reduce bronchoconstriction and mucus secretion
Long-acting muscarinic antagonists (LAMAs) block M3 receptors in airway smooth muscle and mucus glands, producing prolonged bronchodilation and reduced secretions.
Question 6: A COPD patient refuses to quit smoking. What is the most evidence-based pharmacological approach to promote cessation?
- Varenicline (Chantix) combined with behavioral counseling (Correct answer)
- Nicotine replacement therapy alone without counseling
- Bupropion without any behavioral support
- E-cigarettes as a harm reduction strategy
Correct answer: Varenicline (Chantix) combined with behavioral counseling
Varenicline plus behavioral counseling has the highest cessation rates among pharmacological options and is the first-line recommended combination for COPD patients.
Question 7: Which nutritional concern is most commonly associated with advanced COPD and affects prognosis?
- Malnutrition and low BMI linked to increased mortality (Correct answer)
- Obesity only in GOLD Grade 1 patients
- Iron deficiency as the primary nutrient problem
- Vitamin D toxicity from supplementation
Correct answer: Malnutrition and low BMI linked to increased mortality
Malnutrition and cachexia are common in advanced COPD and independently predict higher mortality, making nutritional assessment and support essential.
NAECB COPD Management 3
A COPD patient presents with increased sputum purulence, worsening dyspnea, and increased sputum volume.
These three features together define which clinical condition?